Comparison of the efficacy of rabbit and horse antithymocyte globulin for the treatment of severe aplastic anemia in children
|
Jan 2013
|
Blood
|
aplastic anemia
|
Stem and progenitor cells in myelodysplastic syndromes show aberrant stage specific expansion and harbor genetic and epigenetic alterations.
|
Jul 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes
|
Apr 2023
|
Blood
|
myelodysplastic syndromes (MDS)
|
The myelodysplastic syndrome as a prototypical epigenetic disease.
|
May 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
Allogeneic Stem Cell Transplantations for elderly patients with Myelodysplastic Syndrome
|
Apr 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet.
|
Aug 2013
|
Blood
|
myelodysplastic syndromes (MDS)
|
Phase 2 study of the lenalidomide and azacitidine combination in patients with higher-risk myelodysplastic syndromes.
|
Aug 2012
|
Blood
|
myelodysplastic syndromes (MDS)
|
Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure
|
Jun 2016
|
Blood
|
myelodysplastic syndromes (MDS)
|
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria
|
May 2020
|
Blood
|
aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
Germline DDX41 mutations define a significant entity within adult MDS/AML patients
|
Sep 2019
|
Blood
|
myelodysplastic syndromes (MDS)
|